Articles published by VALNEVA![]() From VALNEVA
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() From VALNEVA
Via GlobeNewswire
![]() ![]() From VALNEVA
Via GlobeNewswire
![]() From VALNEVA
Via GlobeNewswire
![]() ![]() ![]() From VALNEVA
Via GlobeNewswire
![]() From VALNEVA
Via GlobeNewswire
![]() ![]() From VALNEVA
Via GlobeNewswire
![]() ![]() ![]() ![]() From VALNEVA
Via GlobeNewswire
![]()
Valneva Announces Sale of Priority Review Voucher for $103 Million
February 05, 2024
From VALNEVA
Via GlobeNewswire
![]()
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
January 10, 2024
From VALNEVA
Via GlobeNewswire
![]() ![]() ![]()
Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors
December 20, 2023
From VALNEVA
Via GlobeNewswire
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|